Literature DB >> 27716685

Platelet aggregometry interpretation using ROTEM - PART - II.

Vandana Bhardwaj1, Poonam Malhotra Kapoor1.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27716685      PMCID: PMC5070314          DOI: 10.4103/0971-9784.191559

Source DB:  PubMed          Journal:  Ann Card Anaesth        ISSN: 0971-9784


× No keyword cloud information.
The ROTEM platelet system is a new module that can be added to the ROTEM, enabling simultaneous analysis of thromboelastometry measurements and platelet aggregation using impedance aggregometry. Platelet aggregometry using ROTEM Color coded graph for interpretation Reference values of INTEM, HEPTEM, EXTEM, and FIBTEM ROTEM TEMOGRAM with decreased Fibrinogen ROTEM platelet aggregation graph In ROTEM PM, effect of various antiplatelet drugs can be studied through single use agent; ARA-TEM for cyclooxygenase inhibitors, ADP-TEM for ADP receptor blocker and TRAP-TEM for glycoprotein IIbIIIa receptor blockers. ROTEM platelet mapping system ROTEM PM system3 is a new module that can be added to ROTEM, enabling simultaneous analysis of thromboelastometry & platelet aggregation using impedance aggregometry (Figure Below). ROTEM monitor showing simultaneous graphs of thromboelastometry (upper 4) and platelet aggregometry (lower 2) RAPID ASSESSMENT IN ONLY 10 MINUTES IMPEDANCE AGGREGOMETRY: ACTIVATOR PATHWAYS Impedance aggregometry: Activator pathways ROTEM PLATELET ACTIVATORS AND PARAMETERS Platelet aggregometry tests Aratem – Arachidonic acid Traptem – Thrombin activating Peptide Adptem – Adenosine Diphosphate Platelet Parameters Amplitude at 6 Min.-A6 – It describes how well the platelets aggregate after selective activation. Maximum Slope. MS – It describes how quick the platelets aggregate after selective activation. Area Under the Curve-AUC- It reflects the overall platelet aggregation. Graph showing different therapies Graph showing increased and decreased clotting time Administration of fibrinogen concentrate Conclusion: Major bleeding is a partially modifiable risk factor, and adequate preemptive and treatment strategies should be applied to limit this event. ROTEM PLATELET AGGREGOMETRY provides great blood product usage and is cost effective when used in time.
  3 in total

Review 1.  PLATELET FUNCTION IN TRAUMA: IS CURRENT TECHNOLOGY IN FUNCTION TESTING MISSING THE MARK IN INJURED PATIENTS?

Authors:  Jacob B Schriner; Mitchell J George; Jessica C Cardenas; Scott D Olson; Kimberly A Mankiewicz; Charles S Cox; Brijesh S Gill; Charles E Wade
Journal:  Shock       Date:  2022-07-19       Impact factor: 3.533

2.  Relationship between maximum clot firmness in ROTEM® and postoperative bleeding after coronary artery bypass graft surgery in patients using clopidogrel.

Authors:  Rasoul Azarfarin; Fereidoon Noohi; Majid Kiavar; Ziae Totonchi; Avaz Heidarpour; Amir Hendiani; Zahra Sadat Koleini; Saeid Rahimi
Journal:  Ann Card Anaesth       Date:  2018 Apr-Jun

Review 3.  Pharmacokinetic, pharmacodynamic, and pharmacogenetic assays to monitor clopidogrel therapy.

Authors:  Bhawani Yasassri Alvitigala; Lallindra Viranjan Gooneratne; Godwin Roger Constantine; Rajapaksha Arachchige Namal Kumarasiri Wijesinghe; Liyanage Dona Ashanthi Menuka Arawwawala
Journal:  Pharmacol Res Perspect       Date:  2020-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.